News & Events
Meet disruptive innovation at RDD Europe 2019
If you would like to meet at RDD to discuss how our disruptive approach can provide a unique opportunity to you, offering disruptive innovation in respiratory product development, please find us there – we’ll be near our ‘posters’ that are on display, or contact us at email@example.com or call 01633 504776.
Nanopharm is a leading CRO for locally acting nasal and inhaled drug products.
As a contract research organisation in the OINDP space, we provide an integrated, one-stop solution for supporting pre-clinical development programs through to clinic.
Our disruptive approach enables direct access to advanced scientific knowledge at a competitive fee-for-service arrangement.
We offer an integrated approach to product development through device engineering, materials characterisation and formulation design. Our SmartTrackTM service has enabled us to become pioneers of Q3 structural equivalence and in silico modelling of clinical pharmacokinetics.
We are therefore experts in understanding the scientific, technical and regulatory challenges from discovery to IND, de-risking developments and enabling us to enjoy long-term strategic partnerships with our clients.
Dr Jag Shur